Metoprolol Succinate-50mg and Amlodipine Besylate-5mg (Betaker AM 50 Tablets)
Introduction Betaker AM 50 Tablets combine two well-known medications, Metoprolol Succinate (50mg as prolonged release) and Amlodipine Besylate (5mg), to provide effective treatment for hypertension (high blood pressure) and certain cardiovascular conditions. This fixed-dose combination leverages the complementary mechanisms of both drugs to ensure optimal control of blood pressure, reduction in cardiac workload, and prevention of complications such as stroke, heart attack, and kidney problems.
Indications for Metoprolol Succinate-50mg and Amlodipine Besylate-5mg (Betaker AM 50 Tablets)
- Hypertension (High Blood Pressure): To reduce and manage elevated blood pressure levels.
- Stable Angina (Chest Pain): To reduce episodes of chest pain by improving blood flow to the heart.
- Chronic Heart Conditions: In patients with coexisting hypertension and angina.
This medication may also be used under a healthcare provider’s guidance for other cardiovascular conditions.
Administration
To ensure optimal efficacy and safety, Betaker AM 50 Tablets should be taken as prescribed by a healthcare professional. Below are general administration guidelines:
- Dosage: Usually one tablet per day, taken orally.
- Timing: Preferably taken at the same time every day, with or without food.
- Swallowing: Do not crush or chew the tablet as it is a prolonged-release formulation.
- Compliance: Consistency is key to maintaining blood pressure control; do not skip doses.
Always follow the exact dosage and instructions provided by your healthcare provider.
Storage
To maintain the stability and effectiveness of Betaker AM 50 Tablets, adhere to the following storage guidelines:
- Temperature: Store at room temperature (15°C to 30°C).
- Humidity: Keep in a dry place, away from moisture.
- Light: Protect from direct sunlight.
- Child Safety: Store out of reach of children and pets.
Mechanism of Action Metoprolol Succinate-50mg and Amlodipine Besylate-5mg (Betaker AM 50 Tablets)
Betaker AM 50 Tablets deliver a synergistic effect through the combined action of Metoprolol Succinate and Amlodipine Besylate:
- Metoprolol Succinate (50mg): A beta-1 selective adrenergic blocker that reduces heart rate, cardiac output, and myocardial oxygen demand. This helps lower blood pressure and decreases the risk of heart-related complications.
- Amlodipine Besylate (5mg): A calcium channel blocker that relaxes and widens blood vessels by inhibiting the influx of calcium ions into vascular smooth muscle and cardiac cells. This improves blood flow, reduces blood pressure, and alleviates angina symptoms.
Together, these components effectively manage blood pressure and reduce the strain on the heart.
Side Effects
While Betaker AM 50 Tablets are generally well-tolerated, some individuals may experience side effects, including:
- Common Side Effects:
- Dizziness or lightheadedness
- Fatigue
- Slow heart rate (bradycardia)
- Swelling in the ankles or feet (edema)
- Headache
- Serious Side Effects (Rare):
- Severe hypotension (low blood pressure)
- Shortness of breath
- Worsening chest pain
- Irregular heartbeat (arrhythmias)
- Signs of an allergic reaction (rash, itching, swelling, difficulty breathing)
Contact your healthcare provider immediately if serious side effects occur.

Contraindications
Betaker AM 50 Tablets should not be used in the following situations:
- Severe bradycardia (low heart rate)
- Cardiogenic shock
- Second- or third-degree heart block (without a pacemaker)
- Severe hypotension
- Known hypersensitivity to Metoprolol, Amlodipine, or other components of the formulation
- Severe liver impairment
Disclaimer This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your doctor or pharmacist before starting or discontinuing any medication. The use of Betaker AM 50 Tablets should be under the supervision of a qualified healthcare professional. Individual responses to medication may vary, and potential risks or benefits should be discussed with a healthcare provider.